Allarity Therapeutics (Nasdaq: ALLR) is a clinical-stage precision medicine company actively advancing a pipeline of in-licensed oncology therapeutics for patients with difficult-to-treat cancers. The company is leveraging its proprietary, highly accurate Drug Response Predictor (DRP®) technology to refine patient selection and improve clinical outcomes. Publicly traded on NASDAQ, Allarity (ALLR) is headquartered in Boston, MA, while maintaining an R&D facility in Hoersholm, Denmark. Allarity is committed to enhancing patient outcomes through improved decision-making and personalized cancer care.
Company Details
- Employees
- 14
- Founded
- 2012
- Address
- 24 School St, 2nd Floor,denmark
- Phone
- +45 21 60 89 22
- nb****@****ure.com
- Industry
- Pharmaceutical Manufacturing
- NAICS
-
Pharmaceutical and Medicine ManufacturingMedicinal and Botanical ManufacturingPharmaceutical Preparation ManufacturingIn-Vitro Diagnostic Substance ManufacturingBiological Product (except Diagnostic) Manufacturing
- Website
- oncologyventure.com
- HQ
- Boston, Massachusetts
Allarity Therapeutics Questions
Allarity Therapeutics's helpline number is +45 21 60 89 22
Allarity Therapeutics's website is oncologyventure.com
Allarity Therapeutics's LinkedIn profile is https://dk.linkedin.com/company/allaritytx
Allarity Therapeutics has
14 employees.
View email and phone details for 14
employees at Allarity Therapeutics.
Allarity Therapeutics's industry is
Pharmaceutical Manufacturing
Allarity Therapeutics's top competitors are
Rheia Medical,
Nordic Bioscience,
Expres2ion Biotechnologies,
Addex Therapeutics,
Adcendo,
Ascendiant Capital Markets, Llc,
Abeona Therapeutics,
Bioneer A/s,
Cognition Therapeutics, Inc.,
Avenue Therapeutics.
Allarity Therapeutics's support email address is nbj@oncologyventure.com
Allarity Therapeutics's categories are Pharmaceutical Manufacturing
Allarity Therapeutics's founding year is 2012
